Noxopharm
  • Home
  • About Us
    • About Noxopharm
    • Board of Directors
    • Management Team
    • Scientific Advisors
    • Our Focus
    • ASX Announcements
    • Financial Reports
    • Corporate Governance
      • Company Constitution
    • Privacy Policy
    • Sustainability
    • Upcoming Events
  • Our Science
    • About Veyonda®
    • Cancer
    • Septic Shock
    • Our Publications
    • Related Research
    • STING
    • Noxopharm White Papers
    • Why is Noxopharm Different?
  • Our Programs
    • Four Pillars Oncology Program
      • DARRT
      • LuPIN
      • IONIC
      • CEP
    • NOXCOVID COVID-19 Clinical Trial
    • Drug Development Program
    • About Pharmorage
  • Patients
  • Investors
  • Contact Us
    • Contact Us
    • Partnering
    • Working at Noxopharm
    • Newsletter Email Alerts
    • ASX Announcements Email Alerts
About Us
Home > About Us > Corporate Governance > Company Constitution
  • About Noxopharm
  • Board of Directors
  • Management Team
  • Scientific Advisors
  • Our Focus
  • ASX Announcements
  • Financial Reports
  • Corporate Governance
    • Company Constitution
  • Privacy Policy
  • Sustainability
  • Upcoming Events

Company Constitution


 
20-Nov-2019    Noxopharm Constitution - 2019 AGM  
 
3-Jun-2016    Noxopharm Public Company Constitution  
 

Quick Links

Location

Address
Noxopharm Limited
Level 20, Tower A, The Zenith
821 Pacific Highway
CHATSWOOD NSW 2067
or
PO Box 292, Gordon 2072. NSW AUSTRALIA
Telephone:
+ 61 2 9144 2223

ABN
50 608 966 123

Contact us

Email
Shareholder enquiries:
info@noxopharm.com
Patient enquiries:
medical.information@noxopharm.com
My shareholding:
www.automicgroup.com.au

Stay in Touch

Which of the following group do you best fit?

 
Privacy

Email Alerts

Subscribe to our Email Alerts

Follow Us

Subscribe to our Emails and Newsletters

Copyright © Noxopharm
Site Map Privacy Search
Site by